B. Wierusz-Wysocka

发表

Carotid intima-media thickness and arterial stiffness in type 1 diabetic patients with and without microangiopathy

A. Rogowicz-Frontczak, A. Araszkiewicz, S. Piłaciński, 2012, Archives of medical science : AMS.

Clinical research Carotid intima-media thickness and arterial stiffness in type 1 diabetic patients withand without microangiopathy

A. Rogowicz-Frontczak, A. Araszkiewicz, S. Piłaciński, 2012 .

Advanced glycation end products. A new biomarker of diabetes and late complications of disease

A. Araszkiewicz, B. Wierusz-Wysocka, J. Schlaffke, 2013 .

The improvement of metabolic control after using metformin in patients with type 1 diabetes mellitus and excessive visceral fat tissue treated with intensive insulin therapy—pilot study

B. Wierusz-Wysocka, A. Zawada, P. Burchardt, 2015, International Journal of Diabetes in Developing Countries.

Association between adjunctive metformin therapy in young type 1 diabetes patients with excess body fat and reduction of carotid intima-media thickness.

D. Zozulinska-Ziolkiewicz, B. Wierusz-Wysocka, A. Zawada, 2016, Polskie Archiwum Medycyny Wewnetrznej.

Phagocytosis, bactericidal capacity, and superoxide anion (O2-) production by polymorphonuclear neutrophils from patients with diabetes mellitus.

A. Wykrętowicz, B. Wierusz-Wysocka, H. Wysocki, 1985, Folia haematologica.

Polymorphonuclear neutrophils adherence, superoxide anion (O2-) production and HBA1 level in diabetic patients.

A. Wykrętowicz, B. Wierusz-Wysocka, H. Wysocki, 1993, Diabetes research and clinical practice.

The benefi ts of using bolus calculator Bolus Wizard® in patients treated with insulin pumps Medtronic Paradigm®

B. Wierusz-Wysocka, D. Pisarczyk-Wiza, 2013 .

Are zinc transporter type 8 antibodies a marker of autoimmune thyroiditis in non-obese adults with new-onset diabetes?

A. Rogowicz-Frontczak, B. Wierusz-Wysocka, K. Wyka, 2014, European journal of endocrinology.

Does glucagon stimulation test help to predict autoimmunity in newly diagnosed non obese adults with diabetes?

A. Rogowicz-Frontczak, D. Zozulinska-Ziolkiewicz, B. Wierusz-Wysocka, 2012, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Does early insulin treatment decrease the risk of microangiopathy in non-obese adults with diabetes?

B. Wierusz-Wysocka, M. Litwinowicz, Anita Rogowicz, 2007 .

[The role of matrix metalloproteinases in the development of vascular complications of diabetes mellitus--clinical implications].

B. Wierusz-Wysocka, Anita Rogowicz, D. Zozulińska, 2007, Polskie Archiwum Medycyny Wewnetrznej.

Insulin Resistance is Associated with Microangiopathy in Type 1 Diabetic Patients Treated with Intensive Insulin Therapy from the Onset of Disease

A. Araszkiewicz, D. Zozulinska-Ziolkiewicz, B. Wierusz-Wysocka, 2010, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Metformin added to intensive insulin therapy improves metabolic control in patients with type 1 diabetes and excess body fat.

S. Piłaciński, D. Zozulinska-Ziolkiewicz, B. Wierusz-Wysocka, 2018, Polish archives of internal medicine.

Carotid intima-media thickness and arterial stiffness in type 1 diabetic patients are dependent on age and mean blood pressure.

A. Rogowicz-Frontczak, A. Araszkiewicz, S. Piłaciński, 2010, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[Usefulness intima-media thickness of carotid arteries in diagnosis of vascular diabetic complications].

D. Zozulinska-Ziolkiewicz, B. Wierusz-Wysocka, Anita Rogowicz, 2008, Kardiologia polska.

ORIGINAL PAPER High knowledge about diabetes decreases the likelihood of retinopathy in type 1 diabetic patients treated with intensive insulin therapy from the onset of the disease

A. Araszkiewicz, B. Wierusz-Wysocka, D. Zozulińska, 2005 .

Evaluation of the electrochemical skin conduction with the SUDOSCAN+ device in the diagnosis of diabetic neuropathy in patients with type 1 diabetes

A. Araszkiewicz, D. Zozulinska-Ziolkiewicz, B. Wierusz-Wysocka, 2014 .

Evaluation of paraoxonase 1 arylesterase activity and lipid peroxide levels in patients with type 1 diabetes.

A. Araszkiewicz, D. Zozulinska-Ziolkiewicz, B. Wierusz-Wysocka, 2011, Polskie Archiwum Medycyny Wewnetrznej.

The relationship betweenconcentrations of magnesium and oxidized low density lipoprotein and the activity of platelet activating factor acetylhydrolase in the serum of patients with type 1 diabetes

A. Araszkiewicz, B. Wierusz-Wysocka, G. Wegner, 2010 .

The evaluation of IL-12 concentration, PAF-AH, and PLA(2) activity in patients with type 1 diabetes treated with intensive insulin therapy.

A. Araszkiewicz, D. Zozulinska-Ziolkiewicz, B. Wierusz-Wysocka, 2009, Clinical biochemistry.

[Churg-Strauss syndrome: diagnostic and therapeutic challenge - a case report].

B. Wierusz-Wysocka, D. Pisarczyk-Wiza, 2009, Kardiologia polska.

Case reports Churg-Strauss syndrome: diagnostic and therapeutic challenge – a case report

B. Wierusz-Wysocka, D. Pisarczyk-Wiza, 2009 .

Phagocytosis and neutrophil bactericidal capacity in patients with uremia.

R. Czarnecki, A. Wykrętowicz, B. Wierusz-Wysocka, 1984, Folia haematologica.

Serum Nξ-(Carboxymethyl)lysine is Elevated in Nondiabetic Coronary Heart Disease Patients

B. Wierusz-Wysocka, K. Szczawińska, H. Winiarska, 2002, Journal of basic and clinical physiology and pharmacology.

Assessment of skin autofluorescence as a marker of advanced glycation end product accumulation in type 1 diabetes.

A. Araszkiewicz, D. Zozulinska-Ziolkiewicz, B. Wierusz-Wysocka, 2011, Polskie Archiwum Medycyny Wewnetrznej.

C-reactive protein correlates with markers of endothelial dysfunction in type 1 diabetic patients

A. Araszkiewicz, B. Wierusz-Wysocka, M. Sobieska, 2004 .

[Prevalence of chronic complications in patients with over 30-year history of type 1 diabetes depending on the age of onset of diabetes].

S. Piłaciński, D. Zozulinska-Ziolkiewicz, B. Wierusz-Wysocka, 2014, Pediatric endocrinology, diabetes, and metabolism.

Selected aspects of insulin pump theraphy in adults with type 1 diabetes

D. Zozulinska-Ziolkiewicz, B. Wierusz-Wysocka, A. Gawrecki, 2011 .

Selected inflammatory markers as risk factors for diabetic microangiopathy

S. Piłaciński, B. Wierusz-Wysocka, J. Dudziak, 2006 .

Serum interleukin-8 level is increased in diabetic patients

B. Wierusz-Wysocka, K. Wiktorowicz, M. Sobieska, 1999, Diabetologia.

Hepatitis C virus infection: evidence for an association with type 2 diabetes.

B. Wierusz-Wysocka, J. Juszczyk, D. Zozulińska, 2006, Diabetes care.

Metformin added to intensive insulin therapy reduces plasma levels of glycated but not oxidized low‑density lipoprotein in young patients with type 1 diabetes and obesity in comparison with insulin alone: a pilot study.

B. Wierusz-Wysocka, A. Zawada, H. Wysocki, 2013, Polskie Archiwum Medycyny Wewnetrznej.

A. Araszkiewicz, S. Piłaciński, D. Zozulinska-Ziolkiewicz, 2010, Diabetes research and clinical practice.

Association between small fiber neuropathy and higher skin accumulation of advanced glycation end products in patients with type 1 diabetes.

A. Araszkiewicz, D. Zozulinska-Ziolkiewicz, B. Wierusz-Wysocka, 2016, Polskie Archiwum Medycyny Wewnetrznej.

IL-15 is elevated in serum patients with type 1 diabetes mellitus.

B. Wierusz-Wysocka, K. Szczawińska, H. Winiarska, 2005, Diabetes research and clinical practice.

Metabolic control quality and free radical activity in diabetic patients.

A. Wykrętowicz, B. Wierusz-Wysocka, H. Wysocki, 1995, Diabetes research and clinical practice.

Impairment of the oxygen-dependent microbicidal mechanisms of polymorphonuclear neutrophils in patients with type 2 diabetes is not associated with increased susceptibility to infection.

A. Wykrętowicz, B. Wierusz-Wysocka, H. Wysocki, 1993, Diabetes research and clinical practice.

Association between serum adiponectin and HbA1c is independent of the severity of clinical presentation in young adults with new onset type 1 diabetes

S. Piłaciński, D. Zozulinska-Ziolkiewicz, B. Wierusz-Wysocka, 2016, Journal of Endocrinological Investigation.

Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin

B. Wierusz-Wysocka, P. Wysocki, Piotr J Wysocki, 2010, Expert review of molecular diagnostics.

The influence of increasing glucose concentrations on selected functions of polymorphonuclear neutrophils

A. Wykrętowicz, B. Wierusz-Wysocka, R. Klimas, 1988, Acta diabetologia latina.

Association Between IL-6 Concentration and Diabetes-Related Variables in DM1 Patients with and without Microvascular Complications

A. Araszkiewicz, D. Zozulinska-Ziolkiewicz, B. Wierusz-Wysocka, 2013, Inflammation.

Cardiopulmonary Bypass-induced Complement Activation. Evidence for C5a Participation

R. Czarnecki, B. Wierusz-Wysocka, H. Wysocki, 1982, International Journal of Artificial Organs.

Candida-associated denture stomatitis in type 2 diabetes mellitus.

D. Zozulinska-Ziolkiewicz, B. Wierusz-Wysocka, E. Budtz-Jörgensen, 2010, Diabetes research and clinical practice.

Evidence of Polymorphonuclear Neutrophils (PMN) Activation in Patients With Insulin‐Dependent Diabetes Mellitus

A. Wykrętowicz, B. Wierusz-Wysocka, R. Klimas, 1987, Journal of leukocyte biology.

Hematological effects of the new immunosuppressive drug 15-deoxyspergualin.

B. Wierusz-Wysocka, A. Waaga, W. Müller‐ruchholtz, 1993, Archivum immunologiae et therapiae experimentalis.

[Evaluation of glucose, insulin, C-peptide uric acid serum levels in patients with psoriasis].

B. Wierusz-Wysocka, R. Żaba, G. Grzybowski, 2001, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.

Association investigation of BACH2 rs3757247 and SOD2 rs4880 polymorphisms with the type 1 diabetes and diabetes long-term complications risk in the Polish population.

P. Jagodziński, A. Araszkiewicz, D. Zozulinska-Ziolkiewicz, 2015, Biomedical reports.

[Evaluation of the production of superoxide anions (O2-) by neutrophils as an explanation of their impaired bactericidal capacity in patients with diabetes mellitus].

A. Wykrętowicz, B. Wierusz-Wysocka, H. Wysocki, 1984, Polskie Archiwum Medycyny Wewnetrznej.

Increase in glycaemia stimulates reactive oxygen species (ROS) production by polymorphonuclear neutrophils in type 2 diabetic patients

D. Zozulinska-Ziolkiewicz, B. Wierusz-Wysocka, H. Wysocki, 2011 .

Hyperglycaemia and Inflammation are culprits of late diabetic complications

B. Wierusz-Wysocka, D. Zozulińska, 2005 .

Skin autofluorescence is associated with carotid intima-media thickness, diabetic microangiopathy, and long-lasting metabolic control in type 1 diabetic patients. Results from Poznan Prospective Study.

A. Araszkiewicz, S. Piłaciński, D. Zozulinska-Ziolkiewicz, 2015, Microvascular research.

35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts.

Thomas J. Smith, B. M. Rasmussen, V. C. Phan, 1999, Diabetologia.

Increased accumulation of skin advanced glycation end products is associated with microvascular complications in type 1 diabetes.

A. Araszkiewicz, D. Zozulinska-Ziolkiewicz, B. Wierusz-Wysocka, 2011, Diabetes technology & therapeutics.

TG/HDL-C ratio and visceral adiposity index may be useful in assessment of insulin resistance in adults with type 1 diabetes in clinical practice.

D. Zozulinska-Ziolkiewicz, B. Wierusz-Wysocka, P. Niedźwiecki, 2018, Journal of clinical lipidology.

Patients with diabetes type 1 and thyroid autoimmunity have low prevalence of microangiopathic complications

A. Rogowicz-Frontczak, D. Zozulinska-Ziolkiewicz, B. Wierusz-Wysocka, 2015, Endocrine.

Expression of mitochondrial superoxide dismutase in polymorphonuclear leukocytes from patients with type 1 diabetes with and without microvascular complications.

P. Jagodziński, A. Araszkiewicz, D. Zozulinska-Ziolkiewicz, 2014, Polskie Archiwum Medycyny Wewnetrznej.

C‐Reactive protein and soluble intracellular adhesion molecule‐1 are related to pulse wave reflection in type 1 diabetes 在1型糖尿病中C‐反应蛋白以及可溶性细胞间黏附分子在1与脉冲波反射有关

A. Rogowicz-Frontczak, A. Araszkiewicz, S. Piłaciński, 2014, Journal of diabetes.

Does oxidized LDL contribute to atherosclerotic plaque formation and microvascular complications in patients with type 1 diabetes?

A. Araszkiewicz, D. Zozulinska-Ziolkiewicz, B. Wierusz-Wysocka, 2012, Clinical biochemistry.

Prevalence of depressive symptoms and diagnosed depression among subjects with longstanding type 1 diabetes and no serious chronic complications, hospitalized due to inadequate metabolic control of diabetes

D. Zozulinska-Ziolkiewicz, B. Wierusz-Wysocka, Anna Duda-Sobczak, 2017 .

Baseline diabetic knowledge after 5-day teaching program is an independent predictor of subclinical macroangiopathy in patients with type 1 diabetes (Poznan Prospective Study).

A. Araszkiewicz, S. Piłaciński, D. Zozulinska-Ziolkiewicz, 2014, Advances in medical sciences.

Metody oceny mikrokrążenia w skórze u pacjentów z cukrzycą Methods for evaluating the skin microcirculation in patients with diabetes

B. Wierusz-Wysocka, Katarzyna Borucka, 2014 .

1,5-anhydro-D-glucitol: a novel marker of glucose excursions.

B. Wierusz-Wysocka, K. Szczawińska, H. Winiarska, 2002, International journal of clinical practice. Supplement.

The relationship between sudomotor function and skin microvascular reactivity in individuals with type 1 diabetes of long duration.

A. Araszkiewicz, S. Piłaciński, D. Zozulinska-Ziolkiewicz, 2018, Microvascular research.

Psychological and medical problems in prevention and treatment of eating disorders among people with type 1 diabetes

B. Wierusz-Wysocka, Maia Kubiak, Agata Juruć, 2016 .

Albuminuria and VEGF as early markers of cardiovascular disturbances in young type 1 diabetic patients.

D. Zozulinska-Ziolkiewicz, B. Wierusz-Wysocka, H. Wysocki, 2010, Microvascular research.

2019 Guidelines on the management of diabetic patients. A position of Diabetes Poland

D. Moczulski, W. Grzeszczak, A. Araszkiewicz, 2019, Clinical Diabetology.

Type 2 diabetes mellitus as inflammatory disease

B. Wierusz-Wysocka, D. Zozulińska, 2006 .

C-reactive protein and chronic hepatitis C virus infection in diabetic patients.

D. Zozulinska-Ziolkiewicz, B. Wierusz-Wysocka, W. Michalski, 2010, Polskie Archiwum Medycyny Wewnetrznej.

Inflammatory markers as risk factors for microangiopathy in type 1 diabetic patients on functional intensive insulin therapy from the onset of the disease

A. Araszkiewicz, B. Wierusz-Wysocka, D. Zozulińska, 2006 .

Neurodegeneration of the retina in type 1 diabetic patients.

A. Rogowicz-Frontczak, A. Araszkiewicz, S. Piłaciński, 2012, Polskie Archiwum Medycyny Wewnetrznej.

Polymorphonuclear neutrophils function in untreated patients with chronic myeloid leukemia.

A. Wykrętowicz, B. Wierusz-Wysocka, R. Klimas, 1988, Oncology.

[Myocardial infarction in a 26-year-old patient with diabetes type 1].

B. Wierusz-Wysocka, Anita Rogowicz, D. Zozulińska, 2007, Kardiologia polska.

[Diabetes mellitus and psychiatric diseases].

B. Wierusz-Wysocka, Anna Duda-Sobczak, 2011, Psychiatria polska.

Zinc transporter 8 autoantibodies (ZnT8-ab) are associated with higher prevalence of multiple diabetes-related autoantibodies in adults with type 1 diabetes.

A. Rogowicz-Frontczak, S. Piłaciński, D. Zozulinska-Ziolkiewicz, 2018, Diabetes research and clinical practice.

Tonsillectomy due to chronic tonsillitis improves metabolic control in type 1 diabetic patients

D. Zozulinska-Ziolkiewicz, B. Wierusz-Wysocka, P. Niedźwiecki, 2013 .

In diabetic Charcot neuroarthropathy impaired microvascular function is related to long lasting metabolic control and low grade inflammatory process.

A. Araszkiewicz, D. Zozulinska-Ziolkiewicz, B. Wierusz-Wysocka, 2015, Microvascular research.

Small intestinal bacterial overgrowth in adult patients with type 1 diabetes: its prevalence and relationship with metabolic control and the presence of chronic complications of the disease.

A. Araszkiewicz, S. Piłaciński, D. Zozulinska-Ziolkiewicz, 2016, Polskie Archiwum Medycyny Wewnetrznej.

The prevalence incidence of small intestinal bacterial overgrowth (SIBO) in patients with diabetes

A. Araszkiewicz, S. Piłaciński, D. Zozulinska-Ziolkiewicz, 2015 .

Why does intensive insulin therapy implemented at the onset of type 1 diabetes not decrease prevalence of diabetic microangiopathy

A. Araszkiewicz, D. Zozulinska-Ziolkiewicz, B. Wierusz-Wysocka, 2008 .

Insulinoma in a patient with long lasting type 2 diabetes

A. Araszkiewicz, D. Zozulinska-Ziolkiewicz, B. Wierusz-Wysocka, 2009 .

The prevalence of small intestinal bacterial overgrowth ( SIBO ) in adult patients with type 1 diabetes and relationship with metabolic control and the presence of chronic complications of the disease

A. Araszkiewicz, S. Piłaciński, D. Zozulinska-Ziolkiewicz, 2016 .

Smoking and other factors associated with short‐term partial remission of Type 1 diabetes in adults

S. Piłaciński, D. Zozulinska-Ziolkiewicz, B. Wierusz-Wysocka, 2012, Diabetic medicine : a journal of the British Diabetic Association.

Presence of retinopathy in type 1 diabetic patients is associated with subclinical macroangiopathy

A. Rogowicz-Frontczak, A. Araszkiewicz, S. Piłaciński, 2011, Scandinavian journal of clinical and laboratory investigation.

Evaluation of sudomotor function in adult patients with long‑lasting type 1 diabetes.

A. Araszkiewicz, S. Piłaciński, D. Zozulinska-Ziolkiewicz, 2017, Polish Archives of Internal Medicine.

Knowledge after five-day teaching program in intensive insulin therapy performed at the onset of type 1 diabetes influence the development of late diabetic complications.

A. Araszkiewicz, D. Zozulinska-Ziolkiewicz, B. Wierusz-Wysocka, 2008, Diabetes research and clinical practice.

[Carbohydrate metabolism disorders in metabolic syndrome].

B. Wierusz-Wysocka, H. Wysocki, 2005, Kardiologia polska.

The influence of thymus extracts on the chemotaxis of polymorphonuclear neutrophils (PMN) from patients with insulin-dependent diabetes mellitus (IDD).

A. Wykrętowicz, B. Wierusz-Wysocka, H. Wysocki, 1992, Thymus.

Influence of an individual orthopedic equipment on the condition of a foot with neuropathic diabetic foot syndrome

B. Wierusz-Wysocka, M. Stanisić, Adam Węgrzynowski, 2014 .

The influence of insulin-dependent diabetes mellitus (IDDM) duration on superoxide anion and hydrogen peroxide production by polymorphonuclear neutrophils.

A. Wykrętowicz, B. Wierusz-Wysocka, H. Wysocki, 1996, Diabetes research and clinical practice.

[Quality of life in patients with diabetes].

B. Wierusz-Wysocka, D. Zozulińska, Ewelina Pietrzykowska, 2007, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.

Influence of hemodialysis on plasma chemotactic activity and the chemotactic responsiveness of polymorphonuclear neutrophils.

R. Czarnecki, B. Wierusz-Wysocka, H. Wysocki, 1983, Artificial organs.

The relationship between concentrations of magnesium and oxidized low density lipoprotein and the activity of platelet activating factor acetylhydrolase in the serum of patients with type 1 diabetes.

A. Araszkiewicz, D. Zozulinska-Ziolkiewicz, B. Wierusz-Wysocka, 2010, Magnesium research.

Assessment of glycemia in children and adolescents with type 1 diabetes during football tournament

D. Zozulinska-Ziolkiewicz, B. Wierusz-Wysocka, D. Naskręt, 2012 .

Factors associated with early beginning of partial remission in young adult patients with newly diagnosed type 1 diabetes

S. Piłaciński, D. Zozulinska-Ziolkiewicz, B. Wierusz-Wysocka, 2015, International Journal of Diabetes in Developing Countries.

Association Between IL-6 Concentration and Diabetes-Related Variables in DM1 Patients with and without Microvascular Complications

A. Araszkiewicz, D. Zozulinska-Ziolkiewicz, B. Wierusz-Wysocka, 2013, Inflammation.

[The role of matrix metalloproteinases in the development of vascular complications of diabetes mellitus--clinical implications].

B. Wierusz-Wysocka, Anita Rogowicz, D. Zozulińska, 2007, Polskie Archiwum Medycyny Wewnetrznej.

The Selective Polymorphonuclear Neutrophils (PMN) Degranulation as the Probable Additional Mechanism of the Hemodialysis (HD)-induced Complement Activation

R. Czarnecki, A. Wykrętowicz, B. Wierusz-Wysocka, 1981, The International journal of artificial organs.

[Granulocyte aggregation-inducing activity in hemodialysis].

R. Czarnecki, B. Wierusz-Wysocka, H. Wysocki, 1980, Polskie Archiwum Medycyny Wewnetrznej.

Doubts on the diagnosis of type 2 diabetes in patients with hepatitis C virus infection.

B. Wierusz-Wysocka, D. Zozulińska, M. Skowroński, 2006, Diabetes research and clinical practice.